CATH Superfamily 1.10.12.70
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 1: Programmed cell death protein 10
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 7 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
54 |
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
Q8VE70 (/IPI)
(44 more) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
6 | Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
6 | Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
6 | Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) Q9BUL8 (/IPI) |
There are 52 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
49 |
Q6NX65 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
(39 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
49 |
Q6NX65 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
(39 more) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
49 |
Q6NX65 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
(39 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Intrinsic apoptotic signaling pathway in response to hydrogen peroxide GO:0036481
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to hydrogen peroxide (H2O2).
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Wound healing, spreading of cells GO:0044319
The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of Notch signaling pathway GO:0045747
Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Establishment of Golgi localization GO:0051683
The directed movement of the Golgi to a specific location.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of protein serine/threonine kinase activity GO:0071902
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Negative regulation of cell migration involved in sprouting angiogenesis GO:0090051
Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Golgi reassembly GO:0090168
The reformation of the Golgi following its breakdown and partitioning contributing to Golgi inheritance.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of intracellular protein transport GO:0090316
Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Positive regulation of intracellular protein transport GO:0090316
Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.
|
48 |
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
(38 more) |
Negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903588
Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Cellular response to leukemia inhibitory factor GO:1990830
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
|
48 |
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
Q8VE70 (/IEP)
(38 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Intrinsic apoptotic signaling pathway in response to hydrogen peroxide GO:0036481
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to hydrogen peroxide (H2O2).
|
6 | Q9BUL8 (/IGI) Q9BUL8 (/IGI) Q9BUL8 (/IGI) Q9BUL8 (/IGI) Q9BUL8 (/IGI) Q9BUL8 (/IGI) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Wound healing, spreading of cells GO:0044319
The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Positive regulation of Notch signaling pathway GO:0045747
Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Protein stabilization GO:0050821
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Establishment of Golgi localization GO:0051683
The directed movement of the Golgi to a specific location.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Positive regulation of protein serine/threonine kinase activity GO:0071902
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Negative regulation of cell migration involved in sprouting angiogenesis GO:0090051
Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Golgi reassembly GO:0090168
The reformation of the Golgi following its breakdown and partitioning contributing to Golgi inheritance.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Positive regulation of intracellular protein transport GO:0090316
Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903588
Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
|
6 | Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) Q9BUL8 (/IMP) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
2 | Q6NWL1 (/IMP) Q6PHH3 (/IMP) |
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Chordate embryonic development GO:0043009
The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
|
2 | Q6NWL1 (/IGI) Q6PHH3 (/IGI) |
Chordate embryonic development GO:0043009
The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
|
1 | Q6NWL1 (/IMP) |
There are 8 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
49 |
Q6NX65 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
Q8VE70 (/ISS)
(39 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
48 |
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
Q8VE70 (/ISO)
(38 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
7 | Q6NX65 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
6 | Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) Q9BUL8 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
6 | Q9BUL8 (/HDA) Q9BUL8 (/HDA) Q9BUL8 (/HDA) Q9BUL8 (/HDA) Q9BUL8 (/HDA) Q9BUL8 (/HDA) |